The transaction comes as Scholar Rock, now valued at $4.19 billion, trades near its 52-week high of $46.19, having delivered an impressive 186% return over the past year. Investing.com.

Scholar Rock's C-suite now looks radically different, as the company brought in a clutch of new top managers. The incoming CEO is David Hallal, the chairman of the company's board.

While the results were an important proof point for so-called anti-myostatin drugs, Scholar Rock executives indicated the ...

The Glen Rock High School Class of 2016 posted an impressive performance in Advanced Placement exams, School Superintendent Paula Valenti reported at the Sept. 26 Board of Education meeting.

Scholar Rock: Initiation of Patient Dosing in Phase 1 Proof-of-Concept I-O Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy. ... has been truly impressive.

“ Scholar Rock has an impressive pipeline with the potential to meaningfully improve the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders and ...

The John and Mable Ringling Museum of Art's new exhibit, Mountains of the Mind: Scholars’ Rocks from China and Beyond, will open this Saturday, Aug. 5, and run through June 23, 2024, in The ...

Scholar Rock to Host Conference Call to Discuss First Quarter 2025 Financial Results and Provide Business Update on May 14, 2025. Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical ...